Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation

British Journal of Pharmacology

Volumn 118, Issue 6, 1996, Pages 1351-1358

  Ribaldi, E ^a   Mezzasoma, A M ^a   Francescangeli, E ^a   Prosdocimi, M ^b   Nenci, G G ^a   Goracci, G ^a   Gresele, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Fidia Advanced Biopolymers   (Italy)

Author keywords

Antithrombotic agents; Arachidonic acid; Leucocyte activation; Leucocytes; Leukotrienes; PAF; Phospholipase A2; Tissue ischaemia

Indexed keywords

ACYLTRANSFERASE; ANTICOAGULANT AGENT; ARACHIDONIC ACID; CALCIMYCIN; CHOLINEPHOSPHOTRANSFERASE; CLORICROMEN; LEUKOTRIENE; MEPACRINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; ZYMOSAN;

ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; NEUTROPHIL; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

EID: 0029886889     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15544.x     Document Type: Article

References (65)

1. ABRAMSON, S.B., LESZCZYNSKA-PIZIAK, J. & WEISSMAN, G. (1991). Arachidonic acid as a second messenger. Interaction with a GTP-binding protein of human neutrophils. J. Immunol., 147, 231-236.
2. ALBERT, D.H. & SNYDER, F. (1983). Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. J. Biol. Chem., 258, 97-102.
3. ALONSO, F., GIL, M.G., SÁNCHEZ-CRESPO, M. & MATO, J.M. (1982). Activation of 1-alkyl-2-lyso-glycero-3-phosphocholine-acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes. J. Biol. Chem., 257, 3376-3378.
4. APORTI, F., FINESSO, M. & GRANATA, L. (1987). Effect of 8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy-carbonyl-methoxy- coumarin (AD6) on coronary circulation in the dog. Pharmacol. Res. Commun., 10, 469-477.
5. BENVENISTE, J., CHIGNARD, M., LE COUEDIC, J.P. & VARGAFTIG, B.B. (1982). Biosynthesis of platelet-activating (PAF-acether), involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF acether from rabbit platelets. Thromb. Res., 25, 375-385.
6. BERTOCCHI, F., BREVIARIO, F., PROSEPIO, P., MING WANG, J., GHEZZI, P., TRAVAGLI, R.A., PROSDOCIMI, M. & DEJANA, E. (1989). In vitro inhibition of human polymorphonuclear cell function by cloricromene. Naunyn Schmiedeberg's Arch. Pharmacol., 137, 334-342.
7. BLIGH, E.G. & DYER, W.J. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911-917.
8. BOMALASKY, J.S., BAKER, D.G., BROPHY, L. & RESURRECION, N.V. (1989). A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. J. Immunol., 142, 3957-3962.
9. BRAQUET, P., SHEN, T.Y., TOUQUI, L. & VARGAFTIG, B. (1987). Perspectives in platelet-activating factor research. Pharmacol. Rev., 39, 97-145.
10. BRAQUET, P., SPINNEWYN, B., BRAQUET, M., BOURGAIN, R.H., TAYLOR, J.E., ETIENNE, A. & DRIEU, K. (1985). BN52021 and related compounds: a new series of highly specific PAF-acether receptor antagonists isolated from ginkgo biloba. Blood Vessels, 19, 559-572.
11. CAMUSSI, G., TETTA, C., BUSSOLINO, F., METAFORA, S., PELUSO, G., ESPOSITO, C. & PORTA, R. (1990). An antiinflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin. Eur. J. Biochem., 192, 481-485.
12. CHANNON, J.Y. & LESLIE, C.C. (1990). A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem., 265, 5409-5413.
13. CHILTON, F.H., CLUZEL, M. & TRIGGIANI, M. (1991). Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid. Lipids, 26, 1021-1027.
14. CHILTON, F.H., ELLIS, J.M., OLSON, S.C. & WYKLE, R.L. (1984). 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: a common source of platelet-activating factor and arachidonate in human polymorphonuclear leucocytes. J. Biol. Chem., 259, 12014-12019.
15. CIRILLO, R., SALVATICO, E., ALIEV, F. & PROSDOCIMI, M. (1992). The effect of cloricromene during ischemia and reperfusion of rabbit hindlimb: evidence for an involvement of leucocytes in reperfusion-mediated tissue and vascular injury. J. Cardiovasc. Pharmacol., 20, 969-975.
16. DEL MASCHIO, A., BAZZONI, G., ZATTA, A., CHEN, Z.M., DEJANA, E. & PROSDOCIMI, M. (1990). Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline. Eur. J. Pharmacol., 187, 541-545.
17. DENNIS, E.A. (1994). Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem., 269, 13057-13060.
18. DIEZ, E., CHILTON, F.H., STROUP, G., MAYER, R.J., WINKLER, J.D. & FONTEH, A.N. (1994). Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate. Biochem. J., 301, 721-726.
19. DOEBBER, T.W., WU, M.S., ROBBINS, J.C., MA CHOY, B., CHANG, M.N. & SHEN, T.Y. (1985). Platelet activating factor (PAF) involvement in endotoxin induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem. Biophys. Res. Commun., 127, 799-808.
20. FONTEH, A.N., WINKLER, J.D., TORPHAY, T.J., HERAVI, J., UNDEM, B.J. & CHILTON, F.H. (1993). Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil. J. Immunol., 151, 339-350.
21. FRADIN A, ZIRROLLI, J.A., MACLOUF, J., VAUSBINDER, L., HENSON, P.M. & MURPHY, R.C. (1989). Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism. J. Immunol., 143, 3680-3685.
22. GARCIA, C., MONTERO, M., ALVAREZ, J. & SÁNCHEZ CRESPO, M. (1993). Biosynthesis of platelet-activating factor (PAF) induced by chemotactic peptide is modulated at the lyso-PAF: acetyl-CoA acetyltransferase level by calcium transient and phosphatidic acid. J. Biol. Chem., 268, 4001-4008.
23. 2+-dependent route of priming in the production of lipid mediators by human polymorphonuclear leukocytes. J. Biol. Chem., 268, 24751-24757.
24. 2 and specific inhibitors of 5-lipoxygenase. Agents Actions, 34, 89-92.
25. GORACCI, G. & FRANCESCANGELI, E. (1991). Properties of PAF-synthesizing phosphocholinetransferase and evidences for lysoPAF acetyltransferase activity in rat brain. Lipids, 26, 986-991.
26. 4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells. Biochem. Biophys. Res. Commun., 137, 334-342.
27. GRESELE, P., RIBALDI, E., MEZZASOMA, A.M., QUERO, E., STASI, M., PROSDOCIMI, M., GORACCI, G. & NENCI, G.G. (1993). Cloricromene inhibits leukotriene formation by membrane phospholipids. Biochem. Pharmacol., 45, 123-130.
28. HAKIM, G., FIORENTINI, D., FALASCA, A., PROSDOCIMI, M. & ROSSI, C.A. (1988). Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy-carbonyl-methoxy coumarin) on cyclic nucleotide phosphodiesterases in human platelets. Experientia, 44, 226-228.
29. HOFFMAN, S.L., PRESCOTT, S.M. & MAJERUS, P.W. (1982). The effect of mepacrine and p-bromophenacil bromide on arachidonic acid release in human platelets. Arch. Biochem. Biophys., 215, 237-244.
30. KOLTAI, M., HOSFORD, D., FUINOT, P., ESOWU, A. & BRAQUET, P. (1991). Platelet activating factor (PAF). A review of its effects, antagonists and possible future. Clinical implications (Part I). Drugs, 42, 9-29.
31. LAFFI, G., CARLONI, V., BALDI, E., ROSSI, M.E., AZZARI, C., GRESELE, P., MARRA, F. & GENTILINI, P. (1993). Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. Gastroenterology, 105, 170-177.
32. LEYRAVAUD, S., BOSSANT, M.-J., JOLY, F., BESSOU, G., BENVENISTE, J. & NINIO, E. (1989). Biosynthesis of PAF-acether. X. Phorbol myristate acetate-induced PAF-acether biosynthesis and acetyltransferase activation in human neutrophils. J. Immunol., 143, 245-249.
33. LIDBURY, P.S., CIRILLO, R. & VANE, J.R. (1993). Dissociation of the anti-ischemic effect of cloricromene from its anti-platelet activity. Br. J. Pharmacol., 110, 275-280.
34. LOTNER, G.Z., LYNCH, J.M., BETZ, S.J. & HENSON, P. (1980). Human neutrophils derived platelet activating factor. J. Immunol., 124, 676-684.
35. LYNCH, J.M. & HENSON, P.M. (1986). The intracellular retention of newly synthesized platelet-activating factor. J. Immunol., 137, 2653-2661.
36. MARSHALL, L.A., HALL, R.H., WINKLER, J.D., BADGER, A. BOLOGNESE, B., ROSHAK, A., FLAMBERG, P.L., SUNG, C.-M., CHABOT-FLETCHER, M., ADAMS, J.L. & MAYER, R.J. (1995). SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock. J. Pharmacol. Exp. Ther., 274, 1252-1262.
37. NIETO, M.L., VELASCO, S. & SANCHEZ CRESPO, M. (1988a). Biosynthesis of Platelet-activating factor in human polymorphonuclear leucocytes. J. Biol. Chem., 263, 2217 2222.
38. NIETO, M.L. VELASCO, S. & SANCHEZ-CRESPO, M. (1988b). Modulation of acetyl-CoA: 1-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso PAF) acetyltransferase in human polymorphonuclears. The role of cyclic AMP-dependent and phospholipid sensitive, calcium-dependent protein kinases. J. Biol. Chem., 263, 4607-4611.
39. PAGE, C.P. & SPINA, D. (1989). The therapeutic relevance of PAF antagonists. Agent Action (Suppl), 28, 313 329.
40. PINCKARD, R.N., FARR, R.S. & HANAHAN, D.J. (1979). Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF release in vitro from IgE/sensitized basophils. J. Immunol., 123, 1847-1857.
41. PLESZCZYNSKI, M.R. (1990). Priming of human monocytes with PAF augments their production of tumour necrosis factor. J. Lipid. Med., 2, S77-S82.
42. POMPIPOM, M.M., HWANG, S.B., DOEBBER, T.W., ACTON, J.J., ALBERT, A.W., BIFTU, T., BROOKER, D., BUGIANESI, R.L., CHABALA, J.C., GAMBLE, N.L., GRAHAM, D.W., LAM, M.H. & WU, M.S. (1988). (±-trans-2-(3-Methoxy-5-methylsulfony-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran(L-659-989), a novel, potent PAF receptor antagonist. Biochem. Biophys. Res. Commun., 150, 1213 1220.
43. PORCELLATI, S., COSTANTINI, V., PROSDOCIMI, M., STASI, M., PISTOLESI, R., NENCI, G.G. & GORACCI, G. (1990). The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin. Agents Actions, 29, 364 373.
44. PROSDOCIMI, M., FINESSO, M., TESSARI, F., GORIO, P., LANGUINO, L.R., DE GAETANO, G. & DEJANA, E. (1985). Inhibition by AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy-carbonylmethoxy coumarin) of platelet aggregation in dog stenosed artery. Thromb. Res., 39, 399 409.
45. PROSDOCIMI, M., ZATTA, A., GORIO, A., ZANETTI, A. & DEJANA, E. (1986). Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbony-methoxy coumarin) on human platelets in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 305-310.
46. RENOOIJ, W. & SNYDER, F. (1981). Biosynthesis of 1-alkyl-2-acetylsn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. Biochim. Biophys. Acta, 663, 545 556.
47. RIBALDI, E., MEZZASOMA, A.M., PROSDOCIMI, M., NENCI, G.G., GORACCI, G. & GRESELE, P. (1989). AD6 inhibits platelet activating factor-release by human polymorphonuclear leucocytes (PMNs). Thromb. Haemost., 62, 249.
48. SCHEFFE, H. (1959). The Analysis of Variance. New York: J. Wiley & Sons.
49. SCHORER, A.E., DUANE, P.G., WOODS, V.L. & NIEWOEHNE, D.E. (1992). Some antiphospholipid antibodies inhibit phospholipase A2 activity. J. Lab. Clin. Med., 120, 67 77.
50. SHAMSUDDIN, M., ANDERSON, J. & SMITH, L.J. (1995). Differential regulation of leukotriene and platelet-activating factor synthesis in rat alveolar macrophages. Am. J. Respir. Cell. Mol. Biol., 12, 697-704.
51. SILK, S.T., CLEJAN, S. & WITKON, K. (1989). Evidence of GTP-binding protein regulation of phospholipase A2 activity in isolated human platelet membranes. J. Biol. Chem., 264, 21466 21469.
52. 4 metabolism. J. Immunol., 138, 3981 3926.
53. SQUADRITO, F., PROSDOCIMI, M., ALTAVILLA, D., ZINGARELLI, B. & CAPUTI, A.P. (1991). Cloricromene. Cardiovasc. Drug Rev., 9, 357-371.
54. SQUADRITO, F., ALTAVILLA, D., CANALE, P., IOCULANO, M., CAMPO, G.M., AMMENDOLIA, L., FERLITO, M., ZINGARELLI, B., SQAUDRITO, G., SAITTA, A. & CAPUTI, A.P (1994). Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock. Br. J. Pharmacol., 113, 1153 1158.
55. STASI, M., GRESELE, P., PORCELLATI, S., QUERO, E., NENCI, G.G. & GORACCI, G. (1992). Activation of phospholipase A2 and β-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. Biochem. Biophys. Acta, 1124, 279 287.
56. STASI, M., GRESELE, P., PROSDOCIMI M., PORCELLATI, S., QUERO, E., PIERETTI, G., NENCI, G.G. & GORACCI, G. (1993). Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets. J. Lipid. Mediat., 7, 253 267.
57. STEINER, M.R., BOMALASKI, J.S. & CLARK, M.A. (1991). Purification of two phospholipase A2s and characterization of their proinflammatory activities. J. Cell. Biol., 115, 1445 1449.
58. STURK, A., SCHAAP, M.C.L., PRINS, A., TEN CATE, J.W. & VAN DEN BOSCH, H. (1989). Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. Biochem. Biophys. Acta, 993, 148 156.
59. TRANCHINA, S., BERNASCONI, S., DEJANA, E. & DEL MASCHIO, A. (1994). Inhibition of human monocyte adhesion to endothelial cells by the coumarin derivative, cloricromene. Br. J. Pharmacol., 111, 575 581.
60. TRAVAGLI, R.A., ZATTA, A., BAZATTO, N., FINESSO, M., MARIOT, R., TESSARI, F. & PROSDOCIMI, M. (1989). Molecular aspects of cloricromene (AD6) distribution in platelets and its pharmacological effects. Thromb. Res., 54, 327 338.
61. WALSH, C.E., WAITE, B.M., THOMAS, M.J. & DE CHATELET, R. (1981). Release and metabolism of arachidonic acid in human neutrophlils. J. Biol. Chem., 256, 7228-7234.
62. WIJKANDER, J. & SUNDLER, R. (1992). Regulation of arachidonatemobilizing phospholipase A2 by phosphorylation via protein kinase C in macrophages. Febs. Lett., 311, 299 301.
63. WYKLE, R.L. MALONE, B. & SYNDER, F. (1980). Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggegating lipid. J. Biol. Chem., 255, 10256 10260.
64. ZIMMERMANN, G.A., McINTYRE, T.M. & PRESCOTT, S.M. (1985). Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. Circulation, 72, 718 727.
65. ZIMMERMAN, G.A., McINTRYE, T.M. & PRESCOTT, S.M. (1986). Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. Ann. N. Y. Acad. Sci., 485, 349 367.